Incidence of Asymptomatic SARS-CoV-2 Infection in Actively Treated Cancer
Researchers sought to determine the incidence of silent infection with SARS-CoV-2 among patients receiving cancer treatment in Italy during the peak of the pandemic.
Researchers sought to determine the incidence of silent infection with SARS-CoV-2 among patients receiving cancer treatment in Italy during the peak of the pandemic.
In a new study, researchers reported on the frequency of VTE among more than 6000 patients who tested positive for infection with SARS-CoV-2.
A new meta-analysis indicates that the true prevalence of pulmonary hypertension linked to myeloproliferative neoplasms is not well understood.
COVID-19 ICU patients exhibited distinct phenotypic traits that suggested standard VTE prophylaxis is insufficient in this population.
A review of practices prior to a change in nivolumab dosing demonstrated that bodyweight dosing resulted in a 6.1% rate of wastage at a significant cost compared with a fixed dose of 240 mg per dose.
This cross-sectional study investigated the prevalence and severity of cough among patients with lung cancer who are undergoing treatment for their cancer, and compared these results with that of patients with lung cancer who are not undergoing treatment.